MONTEGRESS XL TABLET is a combination of Ambroxol, Levocetirizine and Montelukast which belong to a group of medicines called Mucolytics, Antihistamines and Leukotriene receptor antagonists respectively. It is used to treat chronic obstructive pulmonary disorder, asthma, allergic rhinitis and bronchitis.
Chronic obstructive pulmonary disorder is a chronic inflammatory lung disease that causes obstructed airflow from the lungs which is generally characterized by symptoms such as breathing difficulty, cough, mucus production and wheezing.
Asthma is a lung disease which causes airways to get narrow, swollen and blocked by excess mucus that is characterized by symptoms such as breathing difficulty, cough and wheezing.
Bronchitis is an infection of the main airways of the lungs (bronchi) that cause airways to become irritated and inflamed which is generally characterized by symptoms such as cough, production of mucus, weakness, shortness of breath and chest discomfort.
Avoid taking MONTEGRESS XL TABLET, if you are allergic to Ambroxol, Levocetirizine or Montelukast.
Before taking MONTEGRESS XL TABLET inform your doctor if you have hepatic impairment and kidney problems such as renal impairment.
MONTEGRESS XL TABLET should be used with caution during pregnancy only if it is clearly necessary. It is not recommended for use in breastfeeding women as it can pass through breast milk.
MONTEGRESS XL TABLET is not recommended for use in children and adolescents (below 15 years). Consult your doctor before taking MONTEGRESS XL TABLET.
The most common side effects of taking MONTEGRESS XL TABLET are sleeplessness, skin rash, vomiting, abdominal pain, excess sleepiness, common cold and weakness. Consult your doctor if any of these above side effects gets worse.
It is used to treat:
MONTEGRESS XL TABLET provides symptomatic relief from chronic obstructive pulmonary disorder, asthma, allergic rhinitis and bronchitis. Ambroxol provides relief from symptoms of nasal congestion, allergic cough and rhinorrhea by thinning and loosening the mucus in the nose, windpipe and lungs. Levocetirizine provides relief from itching, swelling and rashes by blocking the effects of a chemical messenger called histamine in the body (which is responsible for producing allergic reactions in the body). Montelukast prevents allergic rhinitis by blocking leukotriene (a chemical messenger) that results in the reduction of inflammation of the airways which provides relief to the symptoms associated with allergies.
Take MONTEGRESS XL TABLET as advised by your physician. Swallow MONTEGRESS XL TABLET with a glass of water and do not chew or crush the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking MONTEGRESS XL TABLET and contact your doctor if you experience any of the following side effects:
Headache:
If MONTEGRESS XL TABLET causes headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of taking MONTEGRESS XL TABLET. If it lasts more than a week or severe, inform your doctor.
Dry mouth :
Try to drink plenty of cold water and sip on cold unsweetened drinks and use lip balm if your lips are dry. Brush your teeth twice a day and use mouthwash. Consult and inform your doctor if the symptom gets worse.
Nausea and Vomiting:
Try to take MONTEGRESS XL TABLET with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult and inform your doctor if the symptom gets worse.
Diarrhea:
Drink plenty of water and stay hydrated. Try to avoid taking any medicine on your own to treat diarrhea. Consult your doctor and inform them if the symptom gets worse.
Tiredness:
Try to take rest and drink plenty of fluids. Avoid or limit the consumption of alcohol. Try to take MONTEGRESS XL TABLET at a time when you can sit down (or lie down) when the symptoms are at their worst. Avoid driving or using tools or machinery until you feel well.
Indigestion:
Try to have smaller and more frequent meals and drink slowly. Reduce consumption of coffee, cola, tea or alcohol and lose weight if you are obese. Try to avoid smoking and don’t have rich, fatty or spicy foods. Consult your doctor and inform if the symptom does not improve.
MONTEGRESS XL TABLET should be used with caution during pregnancy only if it is clearly necessary. Consult your doctor before taking MONTEGRESS XL TABLET.
MONTEGRESS XL TABLET is not recommended for use in breast-feeding women as it may pass through the breast milk. Consult your doctor before taking it.
Do not drive or operate any machines as you may feel reduced mental alertness, dizziness and drowsiness after taking MONTEGRESS XL TABLET.
Avoid consumption of alcohol while taking MONTEGRESS XL TABLET because it may reduce mental alertness.
MONTEGRESS XL TABLET should be used with caution in patients with kidney problems such as renal impairment. Consult your doctor before taking MONTEGRESS XL TABLET.
MONTEGRESS XL TABLET should be used with caution in patients with hepatic impairment. Consult your doctor before taking MONTEGRESS XL TABLET.
Do not take MONTEGRESS XL TABLET if you are allergic to Ambroxol, Levocetirizine, Montelukast or any of its ingredients of this medicine.
Use in Pediatrics:
MONTEGRESS XL TABLET is generally not recommended for use in children and adolescents (below 15 years). Consult your doctor before taking it.
Use in Geriatrics:
MONTEGRESS XL TABLET should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before taking MONTEGRESS XL TABLET.
A. Drug - Drug Interactions:
Before taking MONTEGRESS XL TABLET inform your doctor if you are taking any of the following medicine:
Overdosage:
If you or anyone else accidentally takes too much of MONTEGRESS XL TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are drowsiness, abdominal pain, sleepiness, thirst, headache, vomiting and hyperactivity.
Drug | : | Ambroxol, Levocetirizine, Montelukast |
Pharmacological Category | : | Mucolytics, Antihistamines, Leukotriene receptor Antagonists |
Therapeutic Indication | : | Chronic obstructive pulmonary disorder, Asthma, Allergic rhinitis, Bronchitis |
Dosage Forms | : | Tablet, Capsule, Syrup |
Q: What MONTEGRESS XL TABLET is used for?
A: MONTEGRESS XL TABLET is used to treat chronic obstructive pulmonary disorder (inflammatory lung disease), asthma and allergic rhinitis which is also used to treat bronchitis (viral lung disease).
Q: Who should avoid taking MONTEGRESS XL TABLET?
A: MONTEGRESS XL TABLET is not recommended for use in patients allergic to Ambroxol, Levocetirizine or Montelukast and recommended for use in breastfeeding women and in children and adolescents (below 15 years of age).
Q: What are the side effects of MONTEGRESS XL TABLET?
A: The most common side effects of taking MONTEGRESS XL TABLET are sleeplessness, skin rash, vomiting, abdominal pain, excess sleepiness, common cold and weakness. Consult and inform your doctor if any of these side effects gets worse.
Q: What happens if you take more MONTEGRESS XL TABLET than your required dose?
A: If you or anyone else accidentally takes too much of MONTEGRESS XL TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are drowsiness, abdominal pain, sleepiness, thirst, headache, vomiting and hyperactivity in adults.
Q: Can MONTEGRESS XL TABLET be taken by pregnant or breastfeeding women?
A: MONTEGRESS XL TABLET should be used with caution in pregnant women and recommended in breastfeeding women since it may pass through mother’s milk. Consult your doctor before taking this medicine.
1. KD. Tripathi. Histamine & Antihistaminics and Drugs for Cough and Bronchial Asthma. Seventh edition, 2013. Page – 167, 219 & 228.
2. Ahmad Kantar, Ludger Klimek, Dorotheea Cazan, Annette Sperl, Ulrike Sent and Margarida Mesquita. An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. [Revised in March 2020] [Accessed on 16th June 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137760/
3. UCB, Inc. U.S. Food & Drug Administration. [Revised in January 2008] [Accessed on 16th June 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022064s009lbl.pdf
4. La Renon Healthcare Pvt Ltd. Montegress- XL. [Revised in 2018] [Accessed on 16th June 2022] https://www.larenon.com/wp-content/uploads/2019/01/12.-MONTEGRESS-XL-LBL-FINAL.pdf
5. Amarox Limited. Electronic medicines compendium (EMC). [Revised in November 2020] [Accessed on 16th June 2022] https://www.medicines.org.uk/emc/files/pil.13555.pdf
Written By Dr. Janet.C, Pharm.D
Last updated on 21 Jan 2023 | 06:03 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.